Metropolis Healthcare · NSE: METROPOLIS · BSE: 542650
Q3 FY22 results · Oct–Dec 2021
Metropolis Healthcare reported revenue from operations of ₹293.05 crore (up 6.7% from Q3 FY21) and net profit of ₹41.22 crore (down 29.7% from Q3 FY21) for Q3 FY22 (Oct–Dec 2021), on a consolidated basis.
| Item | Q3 FY22 | Q3 FY21 | YoY | Q2 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 293.05 | 274.78 | +6.7% | 302.62 | −3.2% |
| Other income | 2.61 | 3.74 | −30.2% | 5.57 | −53.2% |
| Total income | 295.66 | 278.52 | +6.2% | 308.19 | −4.1% |
| Profit before tax | 56.09 | 77.77 | −27.9% | 77.71 | −27.8% |
| Net profit for the period | 41.22 | 58.64 | −29.7% | 58.40 | −29.4% |
| Attributable to shareholders of the company | 41.04 | 58.57 | −29.9% | 58.27 | −29.6% |
| EPS, basic (₹) | 8.02 | 11.50 | −30.2% | 11.39 | −29.6% |
| Net margin (%) | 14.1 | 21.3 | 19.3 |
| Item | Q3 FY22 | Q3 FY21 | YoY | Q2 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 212.24 | 224.43 | −5.4% | 241.96 | −12.3% |
| Other income | 1.45 | 2.37 | −38.8% | 3.30 | −56.2% |
| Total income | 213.68 | 226.79 | −5.8% | 245.26 | −12.9% |
| Profit before tax | 33.46 | 64.49 | −48.1% | 59.46 | −43.7% |
| Net profit for the period | 24.86 | 48.70 | −48.9% | 44.47 | −44.1% |
| EPS, basic (₹) | 4.86 | 9.56 | −49.2% | 8.70 | −44.1% |
| Net margin (%) | 11.7 | 21.7 | 18.4 |
Consolidated
- Filed with BSE
- 12 Feb 2022, 14:20 IST
- Board meeting
- 11 Feb 2022
- Period
- 01 Oct 2021 to 31 Dec 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 12 Feb 2022, 14:20 IST
- Board meeting
- 11 Feb 2022
- Period
- 01 Oct 2021 to 31 Dec 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE